Medicine
Maci 15000000/15 cm2 implant
Maci 15000000/15 cm2 implant is a prescription medicine containing Autologous cultured chondrocytes and Pork collagen for intra-articular use, marketed by Vericel, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT REFRIGERATE or FREEZE, or sterilize MACI. Store MACI at room…
Key facts
- Active ingredient (INN)
- Autologous cultured chondrocytes and Pork collagen
- Brand
- Maci
- Strength
- 15000000/15 cm2
- Dosage form
- Implant
- Route
- Intra-articular
- Packs
- 1 bag, 2 bags
- Marketing authorisation holder
- Vericel
- Manufacturer
- Vericel
- Origin register
- US FDA, United States
- Storage
- DO NOT REFRIGERATE or FREEZE, or sterilize MACI. Store MACI at room temperature in its original packaging (outer box) until ready to use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.51Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 June 2017
- Identifiers
- DailyMed set ID 0c336c02-8c4c-4aa8-a992-9d2890a2539cNDC 69866-1030Application BLA125603
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Autologous cultured chondrocytes and Pork collagen is a fixed-dose combination medicine indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the knee, among other approved uses. MedsAcross supplies Autologous cultured chondrocytes and Pork collagen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Autologous cultured chondrocytes and Pork collagenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MACI prescribing information (Vericel) · U.S. National Library of Medicine, DailyMed
Need Maci 15000000/15 cm2 implant for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.